Spero Therapeutics, Inc. (SPRO) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 258K | 39.66M | 3.05M | 11.8M | 5.87M | 15.04M | 13.47M | 10.2M | 4.2M | 73.52M | 25.47M | 2.72M | 2.07M | 46.35M | 1.08M | 896K | 247K | 2.74M | 708K | 2.11M |
| Revenue Growth % | -95.61% | 163.61% | -77.37% | 15.74% | 39.72% | -79.54% | -47.12% | 275.44% | 103.19% | 58.61% | 2254.25% | 203.13% | 737.65% | 1589.29% | 52.82% | -57.45% | -96.62% | 43.89% | -82.28% | 21.95% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 13.61M | 94.63M | 0 | 23.73M | 0 | 49.43M | 619K | 9.51M | 8.98M | 0 | 0 | 0 | 0 | 17.23M | 0 | 0 |
| COGS % of Revenue | - | - | - | - | 231.63% | 629.05% | - | 232.67% | - | 67.24% | 2.43% | 350.15% | 433.98% | - | - | - | - | 627.73% | - | - |
| Gross Profit | 258K | 39.66M | 3.05M | 11.8M | -7.73M | -79.59M | 13.47M | -13.53M | 4.2M | 24.09M | 24.85M | -6.79M | -6.91M | 46.35M | 1.08M | 896K | 247K | -14.48M | 708K | 2.11M |
| Gross Margin % | 100% | 100% | 100% | 100% | -131.63% | -529.05% | 100% | -132.67% | 100% | 32.76% | 97.57% | -250.15% | -333.98% | 100% | 100% | 100% | 100% | -527.73% | 100% | 100% |
| Gross Profit Growth % | 103.34% | 149.83% | -77.37% | 187.24% | -283.92% | -430.41% | -45.81% | -99.12% | 160.84% | -48.03% | 2197.04% | -858.26% | -2897.57% | 420.1% | 52.82% | -57.45% | 102.22% | -859.36% | 105.16% | 21.95% |
| Operating Expenses | 7.8M | 8.25M | 10.96M | 14.25M | 7M | -57.87M | 32.06M | 5.53M | 18.19M | -26.44M | 26.79M | 6.1M | 7.32M | 20.43M | 12.92M | 26.98M | 30.45M | 13.02M | 23.23M | 20.65M |
| OpEx % of Revenue | 3021.71% | 20.81% | 359.71% | 120.71% | 119.15% | -384.64% | 238.04% | 54.26% | 432.59% | -35.97% | 105.16% | 224.45% | 353.65% | 44.07% | 1193.72% | 3010.71% | 12329.55% | 474.53% | 3281.36% | 980.44% |
| Selling, General & Admin | 4.89M | 4.3M | 4.17M | 5.88M | 6.82M | 7.06M | 5.2M | 5.53M | 5.92M | 6.43M | 5.71M | 6.1M | 7.32M | 6.5M | 6.63M | 8.05M | 15.3M | 13.02M | 11.15M | 9.23M |
| SG&A % of Revenue | 1894.19% | 10.84% | 136.94% | 49.81% | 116.17% | 46.9% | 38.59% | 54.26% | 140.75% | 8.75% | 22.41% | 224.45% | 353.65% | 14.01% | 612.94% | 898.55% | 6196.36% | 474.53% | 1575.14% | 438.22% |
| Research & Development | 2.91M | 5.59M | 8.6M | 10.67M | 13.61M | 28.84M | 26.86M | 23.73M | 17.33M | 16.56M | 16.39M | 9.51M | 8.98M | 15.09M | 7.36M | 8.17M | 16.97M | 17.32M | 14.44M | 14.46M |
| R&D % of Revenue | 1127.52% | 14.1% | 282.05% | 90.43% | 231.63% | 191.68% | 199.45% | 232.67% | 412.27% | 22.52% | 64.35% | 350.15% | 433.98% | 32.55% | 680.22% | 912.17% | 6870.85% | 631.38% | 2038.98% | 686.66% |
| Other Operating Expenses | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | 0 | -1000K | -1000K | -1000K | 1000K | -1000K | -1000K | -1000K | -1000K | 1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -7.54M | 31.41M | -7.92M | -2.44M | -14.73M | -21.73M | -18.59M | -19.06M | -13.98M | 50.53M | -1.93M | -12.89M | -14.23M | 25.92M | -11.83M | -26.08M | -30.21M | -27.5M | -22.52M | -18.54M |
| Operating Margin % | -2921.71% | 79.19% | -259.71% | -20.71% | -250.78% | -144.41% | -138.04% | -186.93% | -332.59% | 68.73% | -7.59% | -474.59% | -687.63% | 55.93% | -1093.72% | -2910.71% | -12229.55% | -1002.26% | -3181.36% | -880.44% |
| Operating Income Growth % | 48.83% | 244.56% | 57.42% | 87.18% | -5.36% | -142.99% | -861.38% | -47.87% | 1.72% | 94.92% | 83.66% | 50.58% | 52.9% | 194.26% | 47.46% | -40.65% | -55.68% | -46.32% | -18.42% | -0.36% |
| EBITDA | -7.54M | 31.41M | -7.38M | -2.36M | -14.73M | -20.85M | -18.59M | -19.06M | -13.98M | 50.57M | -1.83M | -12.78M | -14.11M | 26.05M | -11.58M | -25.79M | -30.02M | -27.31M | -22.38M | -18.39M |
| EBITDA Margin % | -2921.71% | 79.19% | -242.19% | -20.01% | -250.77% | -138.58% | -138.03% | -186.92% | -332.59% | 68.78% | -7.17% | -470.62% | -682.17% | 56.2% | -1069.96% | -2877.9% | -12153.04% | -995.3% | -3160.45% | -873.41% |
| EBITDA Growth % | 48.83% | 250.64% | 60.29% | 87.61% | -5.35% | -141.23% | -918.13% | -49.12% | 0.94% | 94.1% | 84.23% | 50.43% | 52.98% | 195.39% | 48.26% | -40.19% | -55.99% | -46.79% | -18.84% | -0.59% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 500 | 0 | 2K | 1K | 0 | 38K | 108K | 108K | 113K | 129K | 257K | 294K | 189K | 191K | 148K | 148K |
| EBIT | -7.54M | 31.41M | -7.38M | -2.36M | -14.56M | -20.85M | -18.59M | -19.06M | -13.98M | 50.53M | 3.37M | -12.89M | -14.23M | 26.77M | -11.68M | -28.57M | -30.34M | -27.5M | -22.52M | -18.57M |
| Net Interest Income | 336K | 376K | 532K | 740K | 864K | 1.03M | 1.18M | 1.2M | 1.33M | 1.04M | 950K | 982K | 963K | 715K | 208K | -6K | -2.42M | -1.86M | 90K | 82K |
| Interest Income | 336K | 376K | 532K | 740K | 864K | 1.03M | 1.18M | 1.2M | 1.33M | 1.04M | 950K | 982K | 963K | 715K | 208K | 111K | 72K | 76K | 90K | 82K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 117K | 2.49M | 1.94M | 0 | 0 |
| Other Income/Expense | 335K | 376K | 534K | 744K | 865K | 1.13M | 1.16M | 1.2M | 1.31M | 1.05M | 940K | 976K | 961K | 847K | 159K | -2.6M | -2.62M | -1.74M | 3K | -30K |
| Pretax Income | -7.2M | 31.78M | -7.38M | -1.7M | -13.87M | -20.6M | -17.44M | -17.86M | -12.67M | 51.58M | -994K | -11.91M | -13.27M | 26.77M | -11.68M | -28.68M | -32.83M | -29.24M | -22.52M | -18.57M |
| Pretax Margin % | -2791.86% | 80.14% | -242.19% | -14.4% | -236.06% | -136.92% | -129.46% | -175.17% | -301.36% | 70.15% | -3.9% | -438.66% | -641.18% | 57.75% | -1079.02% | -3201.12% | -13291.09% | -1065.6% | -3180.93% | -881.86% |
| Income Tax | 0 | 261K | 0 | 0 | 0 | 290K | -290K | 0 | 0 | 387K | 2.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0.82% | 0% | 0% | 0% | -1.41% | 1.66% | 0% | 0% | 0.75% | -222.43% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -7.2M | 31.52M | -7.38M | -1.7M | -13.87M | -20.89M | -17.15M | -17.86M | -12.67M | 51.19M | -3.21M | -11.91M | -13.27M | 26.77M | -11.68M | -28.68M | -32.83M | -29.24M | -22.52M | -18.57M |
| Net Margin % | -2791.86% | 79.48% | -242.19% | -14.4% | -236.06% | -138.85% | -127.31% | -175.17% | -301.36% | 69.63% | -12.58% | -438.66% | -641.18% | 57.75% | -1079.02% | -3201.12% | -13291.09% | -1065.6% | -3180.93% | -881.86% |
| Net Income Growth % | 48.05% | 250.9% | 56.95% | 90.48% | -9.45% | -140.8% | -435.01% | -49.92% | 4.5% | 91.22% | 72.55% | 58.46% | 59.59% | 191.56% | 48.16% | -54.44% | -69.02% | -57.33% | -18.93% | -6.12% |
| Net Income (Continuing) | -7.2M | 31.52M | -7.38M | -1.7M | -13.87M | -20.89M | -17.15M | -17.86M | -12.67M | 51.19M | -3.21M | -11.91M | -13.27M | 26.77M | -11.68M | -28.68M | -32.83M | -29.24M | -22.52M | -18.57M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.13 | 0.53 | -0.13 | -0.03 | -0.25 | -0.39 | -0.32 | -0.33 | -0.24 | 0.96 | -0.06 | -0.23 | -0.23 | 0.55 | -0.33 | -0.87 | -1.09 | -0.91 | -0.70 | -0.63 |
| EPS Growth % | 48% | 235.9% | 59.38% | 90.82% | -4.17% | -140.63% | -426.32% | -43.48% | -4.35% | 74.55% | 81.58% | 73.56% | 78.9% | 160.44% | 52.86% | -38.1% | -65.15% | -33.82% | 18.6% | 25.88% |
| EPS (Basic) | -0.13 | 0.56 | -0.13 | -0.03 | -0.25 | -0.39 | -0.32 | -0.33 | -0.24 | 0.97 | -0.06 | -0.23 | -0.23 | 0.55 | -0.33 | -0.87 | -1.09 | -0.91 | -0.70 | -0.63 |
| Diluted Shares Outstanding | 57.28M | 59.37M | 56.28M | 56.03M | 55.38M | 54.04M | 54.12M | 53.96M | 53.52M | 53.11M | 52.71M | 52.57M | 52.53M | 48.72M | 35.88M | 32.98M | 32.61M | 32.13M | 32.13M | 29.68M |
| Basic Shares Outstanding | 57.28M | 56.02M | 56.28M | 56.03M | 55.38M | 54.04M | 54.12M | 53.96M | 53.52M | 53M | 52.71M | 52.57M | 52.53M | 48.72M | 35.88M | 32.98M | 32.5M | 32.13M | 32.13M | 29.48M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |